BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
T.M. Antonini, D. Samuel. Indications et résultats de la greffe hépatique (hors carcinome hépatocellulaire et hépatite fulminante)Gastroentérologie Clinique et Biologique 2009; 33(1): 44 doi: 10.1016/j.gcb.2008.11.004
2
Dario Degiorgio, Andrea Crosignani, Carla Colombo, Domenico Bordo, Massimo Zuin, Emanuela Vassallo, Marie-Louise Syrén, Domenico A. Coviello, Pier Maria Battezzati. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expressionJournal of Gastroenterology 2016; 51(3): 271 doi: 10.1007/s00535-015-1110-z
3
Yazmín Karel Melchor-Mendoza, Braulio Martínez-Benítez, Aline Mina-Hawat, Gustavo Rodríguez-Leal, Ximena Duque, Segundo Moran-Villota. Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis with Limited Liver Transplantation AvailabilityAnnals of Hepatology 2017; 16(3): 430 doi: 10.5604/01.3001.0009.8598
4
Frederik Nevens. PBC-transplantation and disease recurrenceBest Practice & Research Clinical Gastroenterology 2018; : 107 doi: 10.1016/j.bpg.2018.09.001
5
S. Lüth, C. Weiler-Normann, C. Schramm, A.W. Lohse. Autoimmunerkrankungen der LeberDer Internist 2009; 50(3): 310 doi: 10.1007/s00108-008-2254-1
6
Hui Liu, Hong-Wei Xu, Yu-Zhen Zhang, Ya Huang, Guo-Qing Han, Tie-Jun Liang, Li-Li Wei, Cheng-Yong Qin, Cheng-Kun Qin. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in miceWorld Journal of Gastroenterology 2015; 21(36): 10367-10374 doi: 10.3748/wjg.v21.i36.10367
7
Sehmus Olmez, Suleyman Sayar, Ufuk Avcioglu, İlyas Tenlik, Ersan Ozaslan, Hasan T. Koseoglu, Emin Altiparmak. The relationship between liver histology and noninvasive markers in primary biliary cirrhosisEuropean Journal of Gastroenterology & Hepatology 2016; 28(7): 773 doi: 10.1097/MEG.0000000000000637
8
Marlen Ivón Castellanos Fernández, Deyanira la Rosa Hernández, Diego Enrique Cabrera Eugenio, Wilson Palanca, Zaily Dorta Guridi, Licet González Fabián. Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in CubaCurrent Therapeutic Research 2017; 85: 8 doi: 10.1016/j.curtheres.2017.04.002
9
Aksana Höblinger, Sven Jonas, Gereon Gäbelein, Tillmann Sauerbruch. Viszeralmedizin2015; : 351 doi: 10.1007/978-3-642-14301-4_24
10
Dan Han, Jiayi Liu, Erhu Jin, Wen He. Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patientsJapanese Journal of Radiology 2019; 37(5): 412 doi: 10.1007/s11604-019-00822-6
11
Luciano Adorini, Mark Pruzanski, David Shapiro. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitisDrug Discovery Today 2012; 17(17-18): 988 doi: 10.1016/j.drudis.2012.05.012
12
William Otero R. El hígado en reumatologíaRevista Colombiana de Reumatología 2015; 22(1): 1 doi: 10.1016/j.rcreu.2015.03.002
13
Danielle Cristiane Baldo, Alessandra Dellavance, Maria Lucia Gomes Ferraz, Luis Eduardo C. Andrade. Evolving liver inflammation in biochemically normal individuals with anti-mitochondria antibodiesAutoimmunity Highlights 2019; 10(1) doi: 10.1186/s13317-019-0120-x
14
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseasesJournal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
15
Liam Zakko. Atlas of Dermatological Manifestations of Gastrointestinal Disease2013; : 171 doi: 10.1007/978-1-4614-6191-3_65
16
Pietro Invernizzi, Patrick S. C. Leung, Xiong Ma, M. Eric Gershwin. Liver Immunology2014; : 253 doi: 10.1007/978-3-319-02096-9_18
17
Jing Hieng Ngu, Richard Blair Gearry, Andrew Jeffrey Wright, Catherine Ann Malcolm Stedman. Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population-based studyHepatology International 2012; 6(4): 796 doi: 10.1007/s12072-011-9329-0
18
Tatjana Stojakovic, Thierry Claudel, Csilla Putz-Bankuti, Günter Fauler, Hubert Scharnagl, Martin Wagner, Harald Sourij, Rudolf E. Stauber, Karl Winkler, Winfried März, Thomas C. Wascher, Michael Trauner. Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatmentAtherosclerosis 2010; 209(1): 178 doi: 10.1016/j.atherosclerosis.2009.08.052
19
A Dellavance, LE Coelho Andrade. Immunologic derangement preceding clinical autoimmunityLupus 2014; 23(12): 1305 doi: 10.1177/0961203314531346
20
Frank Czul, Adam Peyton, Cynthia Levy. Primary Biliary CirrhosisClinics in Liver Disease 2013; 17(2): 229 doi: 10.1016/j.cld.2012.12.003
21
Heather Francis, Cynthia J. Meininger. A review of mast cells and liver disease: What have we learned?Digestive and Liver Disease 2010; 42(8): 529 doi: 10.1016/j.dld.2010.02.016
22
Henrik Nilsson, Lennart Blomqvist, Lena Douglas, Anders Nordell, Eduard Jonas. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRIHPB 2010; 12(8): 567 doi: 10.1111/j.1477-2574.2010.00223.x
23
Liam Zakko, Justin Finch, Marti J. Rothe, Jane M. Grant-Kels. Atlas of Dermatological Manifestations of Gastrointestinal Disease2013; : 173 doi: 10.1007/978-1-4614-6191-3_66
24
R. M. Williamson, J. F. Price, S. Glancy, E. Perry, L. D. Nee, P. C. Hayes, B. M. Frier, L. A. F. Van Look, G. I. Johnston, R. M. Reynolds, M. W. J. Strachan. Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes StudyDiabetes Care 2011; 34(5): 1139 doi: 10.2337/dc10-2229
25
Ranjana W. Minz, Navchetan Kaur, Shashi Anand, Ritu Aggarwal, Biman Saikia, Ashim Das, Yogesh K. Chawla. Complete spectrum of AMA-M2 positive liver disease in north IndiaHepatology International 2012; 6(4): 790 doi: 10.1007/s12072-011-9326-3
26
Andreas E Kremer, Christian Rust, Peter Eichhorn, Ulrich Beuers, Stefan Holdenrieder. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markersExpert Review of Molecular Diagnostics 2009; 9(2): 139 doi: 10.1586/14737159.9.2.139
27
Jocelyn Trottier, Andrzej Białek, Patrick Caron, Robert J. Straka, Jenny Heathcote, Piotr Milkiewicz, Olivier Barbier. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot studyDigestive and Liver Disease 2012; 44(4): 303 doi: 10.1016/j.dld.2011.10.025
28
Deepak Garg, Arpit Nagar, Shaile Philips, Naoki Takahashi, Srinivasa R. Prasad, Alampady K. Shanbhogue, Dushyant V. Sahani. Immunological diseases of the pancreatico-hepatobiliary system: update on etiopathogenesis and cross-sectional imaging findingsAbdominal Imaging 2012; 37(2): 261 doi: 10.1007/s00261-011-9759-0